Pasithea Therapeutics Corp
(KTTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,266 | -11,728 | -7,675 | -3,483 | -1,294 |
| Depreciation Amortization | 162 | 5 | 1 | 1 | N/A |
| Other Working Capital | -323 | 845 | -843 | -93 | -209 |
| Other Operating Activity | 225 | -1,017 | -193 | -512 | -650 |
| Operating Cash Flow | $-3,202 | $-11,895 | $-8,709 | $-4,088 | $-2,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -107 | -14 | -9 | -2 |
| Net Acquisitions | N/A | -2,193 | 57 | 77 | N/A |
| Investing Cash Flow | $-54 | $-2,300 | $42 | $68 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 392 | N/A | N/A | N/A | N/A |
| Debt Repayment | -128 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -3,206 | N/A | N/A | N/A |
| Financing Cash Flow | $264 | $-3,206 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -3 | 10 | -130 | -47 | -5 |
| Beginning Cash Position | 33,088 | 52,902 | 52,902 | 52,902 | 52,902 |
| End Cash Position | 29,914 | 33,088 | 42,380 | 47,896 | 50,226 |
| Net Cash Flow | $-3,174 | $-19,814 | $-10,522 | $-5,006 | $-2,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,202 | -11,895 | -8,709 | -4,088 | -2,152 |
| Capital Expenditure | -54 | -107 | -14 | -9 | -2 |
| Free Cash Flow | -3,256 | -12,002 | -8,724 | -4,097 | -2,154 |